+1 (202) 780-3397
Mini Review - Journal of Molecular Oncology Research (2022) Volume 6, Issue 3
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
Whereas essential cytoreductive surgery (PCS) is considered the standard of care for ladies who show with arrange IV endometrial cancer, neoadjuvant chemotherapy (NACT) taken after by interim cytoreductive surgery (ICS) has risen as an elective treatment procedure. We summarized the writing and compared results of PCS compared to NACT and ICS. We conducted an orderly look on PubMed, Embase, Web of Science, and Scopus for articles distributed from January 1, 1990 to December 31, 2020. Key look terms included different descriptors of progressed infection status in combination with “endometrial cancer” and “neoadjuvant chemotherapy. Our audit included considers that inspected survival and surgical results of patients with arrange III or IV endometrial cancer treated with neoadjuvant chemotherapy taken after by interim cytoreductive surgery versus those who gotten essential cytoreductive surgery. We avoided thinks about analyzing as it were patients with leiomyosarcomas, carcinosarcomas, and stromal sarcomas due to the biologic heterogeneity of these malignancies. Endometrial cancer is the foremost common gynecologic cancer in created countries and the fourth most common cancer in ladies. Over 70% of endometrial cancer patients show with organize I illness which is related with a more noteworthy than 90% five year survival rate.
Author(s): Saris Daniel